Evidence map›Paper›PMID 34439409›Full record

ReviewAntioxidants (Basel, Switzerland)2021

Ursolic Acid and Related Analogues: Triterpenoids with Broad Health Benefits.

Huynh Nga Nguyen, Sarah L Ullevig, John D Short, Luxi Wang, Yong Joo Ahn, Reto Asmis

Abstract readReview
In one paragraph

Review in Antioxidants (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. A triterpene-enriched natural extract fromPharmaceutical biology · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Cancer chemoprevention: signaling pathways and strategic approaches.Signal transduction and targeted therapy · 2025
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Huynh Nga NguyenArdelyx Inc., Fremont, CA 94555, USA.
Sarah L UllevigCollege for Health, Community and Policy, University of Texas, San Antonio, TX 78207, USA.ORCID 0000-0001-5322-2801
John D ShortDepartment of Pharmacology, University of Texas Health Science Center, San Antonio, TX 78229-3900, USA.
Luxi WangDepartment of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA.
Yong Joo AhnDepartment of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA.
Reto AsmisDepartment of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA.ORCID 0000-0002-4619-1610

Funding

Role of Glutathione Reductase and Macrophage OncosisR01HL070963 · NHLBI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI ASMIS, RETO H.R. · 2002 to 2010
$2.8M
American Heart Association 0855011FNHLBI NIH HHS HL70963
6 · The paper itself

Abstract

Ursolic acid (UA) is a well-studied natural pentacyclic triterpenoid found in herbs, fruit and a number of traditional Chinese medicinal plants. UA has a broad range of biological activities and numerous potential health benefits. In this review, we summarize the current data on the bioavailability and pharmacokinetics of UA and review the literature on the biological activities of UA and its closest analogues in the context of inflammation, metabolic diseases, including liver and kidney diseases, obesity and diabetes, cardiovascular diseases, cancer, and neurological disorders. We end with a brief overview of UA's main analogues with a special focus on a newly discovered naturally occurring analogue with intriguing biological properties and potential health benefits, 23-hydroxy ursolic acid.

Indexed as

antioxidantsatherosclerosisbotanicalscancerinflammationmetabolic diseasesnutraceutical

Identifiers

PMID34439409
PMCPMC8388988

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.